tiprankstipranks
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
Germany Market
1B1
OncoArendi Therapeutics SA
RESEARCH TOOLSreports

OncoArendi Therapeutics SA (1B1) Cash flow

Compare
0 Followers

OncoArendi Therapeutics SA Cash Flow

DE:1B1's free cash flow for Q4 2025 was zł-3.53M. For the 2025 fiscal year, DE:1B1's free cash flow was decreased by zł61.35M and operating cash flow was zł-3.53M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Mar 24Dec 22Dec 21
Operating Cash Flow
zł -19.41Mzł -56.99Mzł -23.29Mzł -10.21Mzł -13.50M
Investing Cash Flow
zł -16.60Mzł -23.57Mzł -33.87Mzł -33.59Mzł -18.82M
Financing Cash Flow
zł 34.46Mzł 34.76Mzł 55.53Mzł 7.38Mzł 13.86M
End Cash Position
zł 16.35Mzł 18.19Mzł 63.99Mzł 65.62Mzł 102.04M
Free Cash Flow
zł -19.41Mzł -80.76Mzł -23.65Mzł -43.84Mzł -32.33M
Currency in PLN

OncoArendi Therapeutics SA Cash Flow